HomeCTXR • NASDAQ
Citius Pharmaceuticals Inc
add
$2.21
5.24%
After Hours:(0.90%)+0.020
$2.23
Closed: Jul 3, 4:52:58 PM UTC-4 · USD · NASDAQ · Disclaimer
Market news
CNBC
17 hours ago
S&P 500 hits new highs—here's how much $1,000 invested 20 years ago is worth today
0.83%
Reuters
9 hours ago
S&P 500, Nasdaq close at records on jobs data; Nvidia market cap nears $4 trillion
0.83%
0.61%
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 11.26M | 2.65% |
Net income | -10.92M | -27.77% |
Net profit margin | — | — |
Earnings per share | -1.27 | -1.60% |
EBITDA | -11.26M | -2.65% |
Effective tax rate | -2.35% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 26.41K | -99.79% |
Total assets | 121.48M | 33.92% |
Total liabilities | 57.91M | 438.94% |
Total equity | 63.58M | — |
Shares outstanding | 10.29M | — |
Price to book | 0.30 | — |
Return on assets | -23.25% | — |
Return on capital | -42.13% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -10.92M | -27.77% |
Cash from operations | -4.54M | 41.70% |
Cash from investing | — | — |
Cash from financing | 3.47M | — |
Net change in cash | -1.07M | 86.21% |
Free cash flow | -270.66K | 95.63% |
Previous close
$2.10
Day range
$1.99 - $2.48
Year range
$0.65 - $26.25
Market cap
24.70M USD
Avg Volume
4.75M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2007
Headquarters
Website
Employees
23
